After securing over $150 million in transactions boasting $30 million in EBITDA so far in 2021, Viper Equity Partners predicts continued heavy buying in the oral surgery space.
Viper began underwriting oral surgery deals aggressively in October 2020. They also came to market with their OS Prime rollup boasting 70m in annual revenues. “We saw oral surgery as the next big market,” said David C Branch, Viper’s founder. “We put marquee deals together and brought them to some of our Top DSO buyers, in many cases we had to push them to follow our lead and buy.”
Oral surgery has proven to be a huge winner for multi-specialty and Oral Specific DSO’s. Oral surgery offices tend to be very organized, highly profitable and the doctors adapt well to joining large organizations. In an industry that thrives on scale the oral surgery practices produce some of the highest revenue in dentistry with amazingly moderate expenses in most cases. PE firms have also jumped in picking up multi office opportunities with 10m plus in EBITDA as a new vertical. Read more.
